189 related articles for article (PubMed ID: 11428627)
1. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM).
Babin MC; Ricketts K; Skvorak JP; Gazaway M; Mitcheltree LW; Casillas RP
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S141-4. PubMed ID: 11428627
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model.
Casillas RP; Kiser RC; Truxall JA; Singer AW; Shumaker SM; Niemuth NA; Ricketts KM; Mitcheltree LW; Castrejon LR; Blank JA
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S145-51. PubMed ID: 11428628
[TBL] [Abstract][Full Text] [Related]
3. Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model.
Dachir S; Fishbeine E; Meshulam Y; Sahar R; Amir A; Kadar T
Hum Exp Toxicol; 2002 Apr; 21(4):197-203. PubMed ID: 12099621
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokine response in sulfur mustard-exposed mouse skin.
Ricketts KM; Santai CT; France JA; Graziosi AM; Doyel TD; Gazaway MY; Casillas RP
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S73-6. PubMed ID: 11428647
[TBL] [Abstract][Full Text] [Related]
5. A model for quantitative measurement of sulfur mustard skin lesions in the rabbit ear.
Zlotogorski A; Goldenhersh M; Shafran A
Toxicology; 1997 Jun; 120(2):105-10. PubMed ID: 9184197
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits.
Amir A; Turetz J; Chapman S; Fishbeine E; Meshulam J; Sahar R; Liani H; Gilat E; Frishman G; Kadar T
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S109-14. PubMed ID: 11428620
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of topical iodine containing anti-inflammatory drugs against sulfur mustard-induced skin lesions.
Wormser U; Sintov A; Brodsky B; Casillas RP; Nyska A
Arch Toxicol; 2004 Mar; 78(3):156-66. PubMed ID: 14618300
[TBL] [Abstract][Full Text] [Related]
8. Involvement of tumor necrosis factor-alpha in sulfur mustard-induced skin lesion; effect of topical iodine.
Wormser U; Brodsky B; Proscura E; Foley JF; Jones T; Nyska A
Arch Toxicol; 2005 Nov; 79(11):660-70. PubMed ID: 16001271
[TBL] [Abstract][Full Text] [Related]
9. Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice.
Wormser U; Langenbach R; Peddada S; Sintov A; Brodsky B; Nyska A
Toxicol Appl Pharmacol; 2004 Oct; 200(1):40-7. PubMed ID: 15451306
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID.
Dachir S; Fishbeine E; Meshulam Y; Sahar R; Chapman S; Amir A; Kadar T
J Appl Toxicol; 2004; 24(2):107-13. PubMed ID: 15052605
[TBL] [Abstract][Full Text] [Related]
11. TRPA1 and CGRP antagonists counteract vesicant-induced skin injury and inflammation.
Achanta S; Chintagari NR; Brackmann M; Balakrishna S; Jordt SE
Toxicol Lett; 2018 Sep; 293():140-148. PubMed ID: 29535050
[TBL] [Abstract][Full Text] [Related]
12. Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin.
Sabourin CL; Petrali JP; Casillas RP
J Biochem Mol Toxicol; 2000; 14(6):291-302. PubMed ID: 11083082
[TBL] [Abstract][Full Text] [Related]
13. Localization of substance P gene expression for evaluating protective countermeasures against sulfur mustard.
Casbohm SL; Rogers JV; Stonerock MK; Martin JL; Ricketts-Kaminsky KM; Babin MC; Casillas RP; Sabourin CL
Toxicology; 2004 Nov; 204(2-3):229-39. PubMed ID: 15388249
[TBL] [Abstract][Full Text] [Related]
14. Use of the mouse ear vesicant model to evaluate the effectiveness of ebselen as a countermeasure to the nitrogen mustard mechlorethamine.
Lulla A; Reznik S; Trombetta L; Billack B
J Appl Toxicol; 2014 Dec; 34(12):1373-8. PubMed ID: 24347431
[TBL] [Abstract][Full Text] [Related]
15. Investigation of anticholinergic and non-steroidal anti-inflammatory prodrugs which reduce chemically induced skin inflammation.
Young SC; Fabio KM; Huang MT; Saxena J; Harman MP; Guillon CD; Vetrano AM; Heck DE; Flowers RA; Heindel ND; Laskin JD
J Appl Toxicol; 2012 Feb; 32(2):135-41. PubMed ID: 21319177
[TBL] [Abstract][Full Text] [Related]
16. Characterization of acute and long-term sulfur mustard-induced skin injuries in hairless guinea-pigs using non-invasive methods.
Dachir S; Cohen M; Fishbeine E; Sahar R; Brandies R; Horwitz V; Kadar T
Skin Res Technol; 2010 Feb; 16(1):114-24. PubMed ID: 20384890
[TBL] [Abstract][Full Text] [Related]
17. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin.
Yourick JJ; Dawson JS; Mitcheltree LW
J Appl Toxicol; 1995; 15(2):133-8. PubMed ID: 7782559
[TBL] [Abstract][Full Text] [Related]
18. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
19. Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning.
Amitai G; Adani R; Fishbein E; Meshulam H; Laish I; Dachir S
J Appl Toxicol; 2006; 26(1):81-7. PubMed ID: 16167317
[TBL] [Abstract][Full Text] [Related]
20. Topical iodine preparation as therapy against sulfur mustard-induced skin lesions.
Wormser U; Sintov A; Brodsky B; Nyska A
Toxicol Appl Pharmacol; 2000 Nov; 169(1):33-9. PubMed ID: 11076694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
